HK Stock Connect Daily Report: SUNAC Jumps Over 10%, VGT Slips Nearly 13%, Expectations Grow for DIAGENS-B Inclusion in Stock Connect - 20260828

NewTimeSpace · 2026/08/28 17:52 · By Boyuan Chen

NewTimeSpace News: On 28 August 2026, the three major Hong Kong indices ended mixed, with the Hang Seng Index edging up 0.07% to 25,584.79 points, the Hang Seng TECH Index down 0.33%, and turnover at HKD 231.2 billion. Software stocks advanced, with KINGDEE INT'L up 6.23%; gold stocks led gains, with CHINAGOLDINTL up 7.72%; mainland property developers traded actively, with SUNAC up 10.66%. Storage and semiconductor technology names led declines, with VGT down 12.96%; large-model concepts were weak, with Z.AI down over 6% and MINIMAX down over 4%. Southbound capital recorded net buying of HKD 1.176 billion. TIANQI LITHIUM's interim net profit surged 4,925%, GUSHENGTANG's interim profit rose 45.5%, and DIAGENS-B has met the criteria for Stock Connect inclusion.

I. Market Overview

On the trading front, software stocks advanced on Salesforce's better-than-expected results, with KINGDEE INT'L (00268) up 6.23%. Gold stocks led gains, with CHINAGOLDINTL (02099) up 7.72% as spot gold returned to USD 4,600 per ounce. Mainland property developers traded actively, with SUNAC (01918) up 10.66%, as a wave of local real-estate policy easing built momentum for the "golden September and silver October" season. Storage, PCB-concept and semiconductor technology names led declines: VGT (02476) fell 12.96% and GIGADEVICE (03986) dropped 5.81%. Large-model concept stocks were weak, with Z.AI (02513) down over 6% and MINIMAX-W (00100) down over 4%.

Southbound capital recorded net buying of HKD 1.176 billion on the day, comprising HKD 885 million via Stock Connect (Shanghai) and HKD 291 million via Stock Connect (Shenzhen).

II. HK Stock Connect Stock Rankings

2.1 HK Stock Connect Stock Gainers and Decliners

Category	Stock Code	Stock Name	Change (%)	Close (HKD)	Turnover (HKD 100mn)
Gainer 1	06078.HK	HYGEIA HEALTH	12.20	10.58	1.64
Gainer 2	01918.HK	SUNAC	10.66	0.68	6.03
Gainer 3	03339.HK	LONKING	8.90	3.55	1.20
Gainer 4	02273.HK	GUSHENGTANG	8.26	29.10	1.03
Gainer 5	02238.HK	GAC GROUP	7.91	2.25	0.97
Decliner 5	09630.HK	CFMEE	-8.31	342.00	1.81
Decliner 4	00316.HK	OOIL	-8.65	156.20	4.63
Decliner 3	01157.HK	ZOOMLION	-9.35	6.31	2.17
Decliner 2	06185.HK	CANSINOBIO	-9.77	31.76	3.30
Decliner 1	02476.HK	VGT	-12.96	220.20	20.44

Source: Wind, HKEX. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

2.2 HK Stock Connect Active Stocks (ranked by southbound turnover)

Rank	Stock Code	Stock Name	Southbound Turnover (HKD 100mn)	Southbound Net Buy (HKD 100mn)	Change (%)
1	00700.HK	TENCENT	53.63	-1.44	1.65
2	02513.HK	Z.AI	36.87	3.41	-6.03
3	01888.HK	KB LAMINATES	32.41	2.17	2.78
4	06869.HK	YOFC	31.67	2.96	-5.28
5	09988.HK	ALIBABA-W	29.62	-3.81	-1.39
6	00100.HK	MINIMAX-W	29.23	-0.79	-4.51
7	00981.HK	SMIC	20.52	-1.42	-1.61
8	02476.HK	VGT	19.56	4.54	-12.96
9	02628.HK	CHINA LIFE	10.58	-8.78	0.34
10	03986.HK	GIGADEVICE	9.99	1.03	-5.81

III. HK Stock Connect-related A-share ETF Rankings

3.1 HK Stock Connect-related A-share ETF Gainers and Decliners

Category	Code	Short Name	Change (%)	Turnover (RMB 100mn)
Gainer 1	520790	CIB CSI HK Equities Internet ETF	0.97	0.15
Gainer 2	520740	Huaan CSI HK Equities Internet ETF	0.66	0.01
Gainer 3	520910	ChinaAMC CSI HK Equities Internet ETF	0.63	0.30
Gainer 4	159568	Bosera CSI HK Equities Internet ETF	0.62	0.82
Gainer 5	159179	ICBCCS CSI HK Equities Internet ETF	0.61	0.25
Decliner 5	520690	Bosera Hang Seng HK Innovative Drugs Selected ETF	-1.55	0.64
Decliner 4	159286	Penghua CNI HK Equities Innovative Drugs ETF	-1.65	0.73
Decliner 3	159567	Yinhua CNI HK Equities Innovative Drugs ETF	-1.76	8.16
Decliner 2	159570	China Universal CNI HK Equities Innovative Drugs ETF	-1.77	16.87
Decliner 1	159297	China Southern CNI HK Equities Innovative Drugs ETF	-1.81	1.69

Source: Wind. The content of this article is for the objective presentation of data only and does not constitute any investment advice, nor does it represent a recommendation for or value judgment on any security. The market involves risks; investment requires caution.

3.2 HK Stock Connect-related A-share ETF Active Rankings (ranked by turnover)

Rank	Code	Short Name	Tracking Index	Turnover (RMB 100mn)	Turnover Rate (%)	Change (%)
1	159792	Fullgoal CSI HK Equities Internet ETF	CSI HK Equities Internet Index	23.76	6.22	0.52
2	159570	China Universal CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	16.87	6.92	-1.77
3	159131	Hwabao CSI HK Equities Information Technology Integration ETF	CSI HK Equities Information Technology Integration Index	13.22	59.07	-0.41
4	159567	Yinhua CNI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	8.16	10.72	-1.76
5	159316	E Fund Hang Seng HK Innovative Drugs ETF	Hang Seng HK Innovative Drugs Index	6.40	9.91	-1.40
6	526000	ChinaAMC CSI HK Equities Information Technology Integration ETF	CSI HK Equities Information Technology Integration Index	5.75	267.83	-0.50
7	513750	GF CSI HK Connect Financials (ex Banks) Thematic ETF	CSI HK Connect Financials (ex Banks) Thematic Index (RMB)	4.71	3.75	0.39
8	513780	Invesco Great Wall CSI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	4.62	14.23	-1.53
9	520700	Wanjia CSI HK Equities Innovative Drugs ETF	CNI HK Equities Innovative Drugs Index	4.46	61.19	-1.41
10	513770	Hwabao CSI HK Equities Internet ETF	CSI HK Equities Internet Index	3.91	7.59	0.57

IV. Industry and Corporate Updates

1. TIANQI LITHIUM's Interim Net Profit Attributable to Shareholders Surges 4,925%; First-Half Net Profit Reaches RMB 4.242 Billion

On 27 August, TIANQI LITHIUM (09696.HK) released its results for the first half of 2026, with revenue of RMB 12.242 billion, up 153.32% year on year, and net profit attributable to shareholders of the listed company of RMB 4.242 billion, up 4,925.46% year on year. The growth was mainly driven by higher average selling prices and sales volumes of lithium products versus the same period last year. TIANQI LITHIUM is a Stock Connect target.

2. CCTC's Interim Net Profit Attributable to the Parent Reaches RMB 1.932 Billion, Up 56.2% Year on Year

On 27 August, CCTC (06951.HK) released its results for the first half of 2026, with total operating revenue of RMB 6.423 billion, up 54.8% year on year, and net profit attributable to the parent company of RMB 1.932 billion, up 56.2% year on year. Benefiting from growing demand in the electronic components and optical communications industries, MLCC product sales volume and revenue increased substantially year on year. CCTC is a Stock Connect target.

3. GUSHENGTANG's Interim Profit Attributable to Shareholders Reaches RMB 221 Million, Up 45.54% Year on Year, with Interim Dividend Up 2.3 Times

On 28 August, GUSHENGTANG (02273.HK) released its interim results for 2026, with first-half revenue of RMB 1.653 billion, up 10.57% year on year, and profit attributable to shareholders of RMB 221 million, up 45.54% year on year. The company proposed an interim dividend of HKD 1.15 per share, versus HKD 0.35 per share in the same period last year, an increase of nearly 2.29 times year on year. GUSHENGTANG is a Stock Connect target.

4. DIAGENS-B Meets Criteria for Stock Connect Inclusion, the Sole New Addition to the Hang Seng Hong Kong-Listed Biotech Index

On 24 August, DIAGENS-B (02526.HK) announced that it had been included by Hang Seng Indexes Company Limited in the Hang Seng Composite Index and the Hang Seng Hong Kong-Listed Biotech Index, effective 7 September. The company has met the criteria for inclusion in Stock Connect trading and is the only company newly added to the Hang Seng Hong Kong-Listed Biotech Index in this index review. DIAGENS-B is a potential Stock Connect target.

5. Medcaptain Medical Technology Kicks Off Public Offering Today; Application Fee Approximately HKD 1,557.55; Listing Expected on 7 September

On 28 August, medical device supplier Medcaptain Medical Technology Co., Ltd. (02041.HK) announced details of its Hong Kong offering, planning a global offering of 38,910,600 H-shares at an offer price of HKD 15.42 per share, with a board lot of 100 shares and an application fee of approximately HKD 1,557.55. The offer period runs from today until 2 September, with listing expected on 7 September.

V. Market Notes

Eligible securities list adjustment announcement

No recent announcements.

Trading calendar

No approaching market closure days.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

HK Stock Connect Daily Report HYGEIA HEALTH Tencent CIB CSI HK Equities Internet ETF Fullgoal CSI HK Equities Internet ETF